Related Experiment Video
Updated: Sep 25, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
Sick Leave in Patients with Inflammatory Bowel Disease Before and After Diagnosis: A Retrospective Matched Cohort
Annika Fernandez Milano1, Sarah Krieg2, Karel Kostev1,3
1Epidemiology, IQVIA, 60549 Frankfurt am Main, Germany.
Background/Objectives:
Inflammatory bowel disease (IBD) can affect work participation. Evidence on sick leave among IBD patients in Germany is limited. We compared the occurrence and duration of certified sick leave between IBD patients and non-IBD controls.
Methods:
Practice data from the Disease Analyzer database in Germany were used. Newly diagnosed IBD patients were matched to non-IBD controls using propensity scores. Sick leave occurrence and duration were evaluated in the year before and two years after diagnosis, using logistic and zero-inflated negative binomial regression, respectively. Stratified analyses explored variations by IBD subtype, sex, and age group.
Results:
Sick leave occurred more frequently in IBD patients than controls pre-index (45.7% vs. 42.2%) and during the second year post-index (49.6% vs. 42.5%), consistent with higher odds in these periods (odds ratio (OR) 1.17, 95% confidence interval (CI) 1.11-1.22 and OR 1.35, 95% CI 1.29-1.42, respectively) but not during the first year post-index, when proportions were highest in both cohorts (56.2% vs. 56.4%). While median sick leave durations were low in both cohorts (0-2 days), mean durations were higher among IBD patients. In the second year post-index, IBD patients had 1.59 times (95% CI 1.50-1.69) more sick leave days than controls. Stratified analyses suggested higher sick leave estimates in ulcerative colitis than Crohn's disease, more frequent sick leave in younger patients, and longer mean sick leave durations in older patients.
Conclusions:
IBD is associated with a greater certified sick leave burden before and after diagnosis, although absolute differences compared with controls were modest.
More Related Videos
09:44Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation
Published on: September 11, 2012
08:27Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease IV: Clinical Manifestations